Cerebral vasospasm after subarachnoid hemorrhage: An update

Annals of Neurology

Volumn 14, Issue 6, 1983, Pages 599-608

  Heros, Roberto C ^a   Zervas, Nicholas T ^a   Varsos, Vassilios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD VESSEL VOLUME; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM; COLLOID; CONSCIOUSNESS; DIAGNOSIS; ETIOLOGY; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR SYSTEM; REVIEW; SUBARACHNOID HEMORRHAGE; THERAPY;

BLOOD PRESSURE; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; HUMAN; ISCHEMIC ATTACK, TRANSIENT; MUSCLE, SMOOTH, VASCULAR; SUBARACHNOID HEMORRHAGE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021017795     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410140602     Document Type: Article

References (109)

1. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage
2. Experimental catecholamineinduced cerebral vasospasm: Myonecrosis in vessel wall
3. Ruptured I‐C aneurysms: the role of arterial spasm
4. Cerebral arterial spasm. VIII. The treatment of delayed cerebral arterial spasm in human beings
5. Cerebral arterial spasm: a controlled trial of nimodipine in subarachnoid hemorrhage patients: the nimodipinecerebral arterial spasm study group (abstract)
6. Cerebral arterial spasm. I. In vitro contractile activity ofvasoactive agents on canine basilar and middle cerebral arteries
7. Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition
8. The role of mechanical factors in the pathogenesis of short‐term and prolonged spasm of the cerebral arteries
9. Phosphorylation by cyclic adenosine 3′:5′‐monophosphate‐dependent protein kinase regulates myosin light chain kinase
10. Structural changes of the intradural arteries following subarachnoid hemorrhage
11. Preoperative arteriographic spasm and outcome from aneurysm operation
12. Electrocardiographic changes and their prognostic significance in subarachnoid hemorrhage
13. Modulator protein as a component of myosin light chain kinase
14. A neuroradiologic approach to the patient with a diagnosis of subarachnoid hemorrhage
15. Management of cerebral aneurysm
16. Vasospasm and focal ischemia: an experimental study
17. Current concepts in the etiology and treatment of vasospasm
18. Autonomic nerves, mast cells, and amine receptors in human brain vessels: a histochemical and pharmacological study
19. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning
20. Cerebral vasospasm with ruptured saccular aneurysms: the clinical manifestations
21. Phosphodiesterase inhibitors and cerebral vasospasm
22. Aminophylline and isoproterenol in the treatment of cerebral vasospasm
23. Cerebral vasospasm in angiography for intracranial aneurysms: Incidence and significance in one hundred consecutive angiograms
24. Noradrenergic mediation of experimental cerebrovascular spasm
25. Reversal of experimental delayed cerebral vasospasm by angiotensin‐converting enzyme inhibition
26. Total morbidity and mortality rates of patients with surgically treated intracranial aneurysms
27. Diagnosis and treatment of postoperative cerebral vasospasm
28. Cooperative study of intracranial aneurysms and subarachnoid hemorrhage
29. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans
30. The effects of a calcium antagonist, nimodipine, upon physiologic responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia
31. Regional cerebral blood flow studies in subarachnoid hemorrhage
32. Intracranial arterial aneurysm: an update
33. Cerebral vasospasm
34. Cerebral artery spasm: a histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage
35. Regional cerebral blood flow in patients with ruptured intracranial aneurysms
36. Arterial spasm in subarachnoid hemorrhage: mechanical considerations
37. Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage (abstract)
38. Cerebral arterial spasm. II. Experimental evaluation of mechanical and humoral factors in pathogenesis
39. Overall management of ruptured aneurysm: comparison of early and late operation
40. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension
41. Volume expansion in focal cerebral ischemia: the effect of cardiac output on local cerebral blood flow
42. Intravenous nitroglycerin in experimental cerebral vasospasm: a preliminary report
43. Medical management of patients following a ruptured cerebral aneurysm with epsilonaminocaproic acid, kanamycin and reserpine
44. Postoperative hypertension in the management of patients with intracranial arterial aneurysms
45. Role of prostaglandin F2 in human cerebral vasospasm
46. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall
47. Results of early operations for ruptured aneurysms
48. Early management of aneurysmal subarachnoid hemorrhage
49. Hypovolemia in patients with subarachnoid hemorrhage: therapeutic implications
50. Prevention of vasospasm by early operation with removal of subarachnoid blood
51. Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture
52. Cyclic AMP‐dependent inhibition of smooth muscle actomyosin
53. The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage
54. Innervation of intracranial arteries
55. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SAIDH)
56. Intracranial aneurysms and subarachnoid hemorrhage: a cooperative study: antifibrinolytic therapy in recent onset subarachnoid hemorrhage
57. Adrenergic innervation of pial arteries related to the circle of Willis in the cat
58. The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysms
59. Possible role of the erythrocyte in causing prolonged cerebral vasospasm
60. Pre‐ and postoperative management of cerebral aneurysms
61. Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys
62. Plasma catecholamines following subarachnoid hemorrhage
63. Adrenergic innervation of the cerebral blood vessels in the rabbit
64. Role of prostaglandin F2 in the genesis of experimental cerebral vasospasm: angiographic study in dogs
65. Cerebral vasospasm
66. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion
67. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysms
68. Vasospasm assessed by angiography and computerized tomography
69. Significance of vasospasm in the treatment of ruptured intracranial aneurysms
70. Risk of intracranial aneurysm surgery in the good grade patient: early versus late operation
71. Timing and indication of surgery for ruptured intracranial aneurysms with regard to cerebral vasospasm
72. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage
73. Intracranial aneurysm rupture, vasospasm and infarction
74. 2+, calmodulin and cyclic AMP–dependent modulation of actin‐myosin interaction in aorta
75. Management of ischemic complications after subarachnoid hemorrhage
76. Results and complications of surgical management of 809 intracranial aneurysms in 722 cases
77. Physiological considerations important for the management of vasospasm
78. Results of early operations on cerebral aneurysms
79. Vasospasm in aneurysm
80. Autoregulation in acute focal ischemia: an experimental study
81. Fluid and electrolyte disturbances in patients with intracranial aneurysms
82. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall: an experimental study
83. Effect of early operation for ruptured aneurysm on prevention of delayed ischemic symptoms
84. Intercellular granules and vesicles in prolonged cerebral vasospasm
85. Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries
86. Mechanism of cerebral arterial contraction induced by blood constituents
87. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a “two‐hemorrhage” canine model
88. Cerebral blood flow and intracranial pressure in the dog during intravenous infusion of nitroglycerin alone and in combination with dopamine
89. The effect of phentolamine and propranolol in subarachnoid hemorrhage
90. Time course of vasospasm in man
91. Cerebral vasoactivity of heme proteins in vitro: some mechanistic considerations
92. Experimental study on the genesis of cerebral vasospasm
93. Attempts at treatment of intracranial arterial spasm in animals and human beings
94. Hypothalamic dysfunction and intracranial arterial spasm
95. Attempted prevention or treatment of intracranial arterial spasm: a survey
96. Update: subarachnoid hemorrhage and saccular intracranial aneurysms
97. Intracranial arterial spasm: a clinical analysis
98. Rheological aspects of experimental hypervolemic hemodilution with low molecular weight dextran: relationships of cortical blood flow, cardiac output, and intracranial pressure to fresh blood viscosity and plasma volume
99. Failure of intravascular volume expansion without hemodilution to elevate cortical blood flow in region of experimental focal ischemia
100. Catecholamines
101. Experimental vasoconstriction of cerebral arteries by prostaglandins
102. Morphological changes in cerebral vessels in experimental cerebral vasospasms
103. Vasospasm: an update
104. Reduced incidence of cerebral ischemia following rupture of intracranial aneurysms
105. Experimental inhibition of serotonin by antibiotic: prevention of cerebral vasospasm
106. Cerebral arterial spasm: modification by inhibition of platelet function
107. Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum
108. Current concepts in experimental cerebral vasospasm